These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24937592)

  • 1. Nerve growth factor promotes killing of Leishmania donovani by macrophages through the induction of hydrogen peroxide.
    Chiba R; Amagai Y; Tanaka A; Katakura K; Matsuda H
    Microbes Infect; 2014 Aug; 16(8):702-6. PubMed ID: 24937592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.
    Bimal S; Sinha S; Singh SK; Narayan S; Kumar V; Verma N; Ranjan A; Sinha PK; Das VN; Pandey K; Kar SK; Das P
    Exp Parasitol; 2012 Jul; 131(3):274-82. PubMed ID: 22580024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy.
    Carter KC; Hutchison S; Boitelle A; Murray HW; Sundar S; Mullen AB
    Parasitology; 2005 Dec; 131(Pt 6):747-57. PubMed ID: 16336728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.
    Pal S; Ravindran R; Ali N
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3591-3. PubMed ID: 15328135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
    Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains.
    Bhaumik SK; Paul J; Naskar K; Karmakar S; De T
    J Antimicrob Chemother; 2012 Apr; 67(4):910-20. PubMed ID: 22258930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB/c mice.
    Joshi J; Kaur S
    Parasitology; 2014 Apr; 141(4):554-62. PubMed ID: 24618257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous interleukin-18 is involved in immunity to Leishmania donovani but its absence does not adversely influence the therapeutic activity of sodium stibogluconate.
    Mullen AB; Lawrence CE; McFarlane E; Wei XQ; Carter KC
    Immunology; 2006 Nov; 119(3):348-54. PubMed ID: 16879623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sodium stibogluconate and pentamidine on in vitro multiplication of Leishmania donovani in peritoneal macrophages from infected and drug-treated BALB/c mice.
    Sodhi S; Kaur S; Mahajan RC; Ganguly NK; Malla N
    Immunol Cell Biol; 1992 Feb; 70 ( Pt 1)():25-31. PubMed ID: 1322361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
    Escobar P; Yardley V; Croft SL
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
    Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection.
    Mukherjee S; Mukherjee B; Mukhopadhyay R; Naskar K; Sundar S; Dujardin JC; Roy S
    J Immunol; 2014 Oct; 193(8):4083-94. PubMed ID: 25217162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt5a Signaling Promotes Host Defense against
    Chakraborty A; Kurati SP; Mahata SK; Sundar S; Roy S; Sen M
    J Immunol; 2017 Aug; 199(3):992-1002. PubMed ID: 28659356
    [No Abstract]   [Full Text] [Related]  

  • 14. Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase.
    Murray HW; Xiang Z; Ma X
    Am J Trop Med Hyg; 2006 Jun; 74(6):1013-5. PubMed ID: 16760512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic and prophylactic uses of protein A in the control of Leishmania donovani infection in experimental animals.
    Ghose AC; Mookerjee A; Sengupta K; Ghosh AK; Dasgupta S; Ray PK
    Immunol Lett; 1999 Feb; 65(3):175-81. PubMed ID: 10065740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunct effect of immunostimulating hexapeptide analogous to human beta-casein fragment (54-59) to sodium stibogluconate against experimental visceral leishmaniasis.
    Gupta S; Srivastava VM; Puri A; Pandey D; Haq W
    Immunopharmacol Immunotoxicol; 2004 Aug; 26(3):425-34. PubMed ID: 15518175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis.
    Roberts WL; Hariprashad J; Rainey PM; Murray HW
    Am J Trop Med Hyg; 1996 Oct; 55(4):444-6. PubMed ID: 8916804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of rutin, a potent flavonoid against SSG-sensitive and -resistant Leishmania donovani parasites in experimental leishmaniasis.
    Chauhan K; Kaur G; Kaur S
    Int Immunopharmacol; 2018 Nov; 64():372-385. PubMed ID: 30245348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cured immune phenotype achieved by treatment of visceral leishmaniasis in the BALB/c mouse with a nonionic surfactant vesicular formulation of sodium stibogluconate does not protect against reinfection.
    Carter KC; Baillie AJ; Mullen AB
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):61-5. PubMed ID: 9874665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-γ-induced macrophage antileishmanial mechanisms in mice: A role for immunity-related GTPases, Irgm1 and Irgm3, in Leishmania donovani infection in the liver.
    Murray HW; Mitchell-Flack M; Taylor GA; Ma X
    Exp Parasitol; 2015 Oct; 157():103-9. PubMed ID: 26208780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.